On October 19, 2018 Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient’s immune system against cancer, reported it will present at The Cellular "Living Drug" Revolution Summit being held next Thursday, October 25, 2018, at 6:00 PM, ET in New York City (Press release, Heat Biologics, OCT 19, 2018, View Source [SID1234529974]). John Prendergast, PH.D., Heat’s Lead Independent Director, will be presenting on the panel.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The event brings executives from leading cell therapy companies together to discuss where the industry is headed and how their companies, individually and collectively, are helping advance the industry into a new era. Investors interested in attending the event can register at: https://investmentstrategiesinanewmedi.splashthat.com/